These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 35453337)

  • 1. Erythropoietin as a Neuroprotective Drug for Newborn Infants: Ten Years after the First Use.
    Perrone S; Lembo C; Gironi F; Petrolini C; Catalucci T; Corbo G; Buonocore G; Gitto E; Esposito SMR
    Antioxidants (Basel); 2022 Mar; 11(4):. PubMed ID: 35453337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL): A Randomized Controlled Trial - Background, Aims, and Study Protocol.
    Juul SE; Comstock BA; Heagerty PJ; Mayock DE; Goodman AM; Hauge S; Gonzalez F; Wu YW
    Neonatology; 2018; 113(4):331-338. PubMed ID: 29514165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Neonatal Hypoxic-Ischemic Encephalopathy with Erythropoietin Alone, and Erythropoietin Combined with Hypothermia: History, Current Status, and Future Research.
    Oorschot DE; Sizemore RJ; Amer AR
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin in perinatal hypoxic-ischemic encephalopathy: a systematic review and meta-analysis.
    Razak A; Hussain A
    J Perinat Med; 2019 May; 47(4):478-489. PubMed ID: 30789826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin: a novel therapy for hypoxic-ischaemic encephalopathy?
    Wu YW; Gonzalez FF
    Dev Med Child Neurol; 2015 Apr; 57 Suppl 3():34-9. PubMed ID: 25800490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Erythropoietin in the management of Hypoxic Ischaemic Encephalopathy in resource-constrained settings: protocol for a randomized control trial.
    Ezenwa B; Ezeaka C; Fajolu I; Ogbenna A; Olowoyeye O; Nwaiwu O; Opoola Z; Olorunfemi G
    BMC Neurol; 2020 May; 20(1):171. PubMed ID: 32366288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic hypothermia in the prevention of hypoxic-ischaemic encephalopathy: new categories to be enrolled.
    Gancia P; Pomero G
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():94-6. PubMed ID: 22958032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin for infants with hypoxic-ischemic encephalopathy.
    McPherson RJ; Juul SE
    Curr Opin Pediatr; 2010 Apr; 22(2):139-45. PubMed ID: 20090525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of EPO combined with mild hypothermia on oxidative stress and neuroprotection in neonates with hypoxic-ischemic encephalopathy.
    Xu Y; Huang L; Han J; Zhou Y
    Cell Mol Biol (Noisy-le-grand); 2022 Apr; 68(4):36-45. PubMed ID: 35988285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Dose Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy: A Phase II Trial.
    Wu YW; Mathur AM; Chang T; McKinstry RC; Mulkey SB; Mayock DE; Van Meurs KP; Rogers EE; Gonzalez FF; Comstock BA; Juul SE; Msall ME; Bonifacio SL; Glass HC; Massaro AN; Dong L; Tan KW; Heagerty PJ; Ballard RA
    Pediatrics; 2016 Jun; 137(6):. PubMed ID: 27244862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose erythropoietin population pharmacokinetics in neonates with hypoxic-ischemic encephalopathy receiving hypothermia.
    Frymoyer A; Juul SE; Massaro AN; Bammler TK; Wu YW
    Pediatr Res; 2017 Jun; 81(6):865-872. PubMed ID: 28099423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics.
    Wu YW; Bauer LA; Ballard RA; Ferriero DM; Glidden DV; Mayock DE; Chang T; Durand DJ; Song D; Bonifacio SL; Gonzalez FF; Glass HC; Juul SE
    Pediatrics; 2012 Oct; 130(4):683-91. PubMed ID: 23008465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia.
    Traudt CM; McPherson RJ; Bauer LA; Richards TL; Burbacher TM; McAdams RM; Juul SE
    Dev Neurosci; 2013; 35(6):491-503. PubMed ID: 24192275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin for neonatal brain injury: opportunity and challenge.
    Xiong T; Qu Y; Mu D; Ferriero D
    Int J Dev Neurosci; 2011 Oct; 29(6):583-91. PubMed ID: 21277366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of erythropoietin in neonates with hypoxic-ischemic encephalopathy receiving therapeutic hypothermia.
    Lin TH; Chen CH; Ko MH; Tsai JD; Jeng MJ
    J Chin Med Assoc; 2023 May; 86(5):515-522. PubMed ID: 36762934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of monotherapy with erythropoietin in neonatal hypoxic-ischemic encephalopathy on neurobehavioral development: a systematic review and meta-analysis.
    Liu TS; Yin ZH; Yang ZH; Wan LN
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2318-2326. PubMed ID: 33755969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged astrocyte-derived erythropoietin expression attenuates neuronal damage under hypothermic conditions.
    Toriuchi K; Kakita H; Tamura T; Takeshita S; Yamada Y; Aoyama M
    J Neuroinflammation; 2020 May; 17(1):141. PubMed ID: 32359362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Postnatal Administration of Erythropoietin and Its Association with Neurodevelopmental Outcomes and Incidence of Intraventricular Hemorrhage and Hypoxic-Ischemic Encephalopathy: A Four-Week Observational Study.
    Costescu OC; Manea AM; Boia ER; Cioboata DM; Doandes FM; Enatescu I; Costescu S; Prodan M; Boia M
    Pediatr Rep; 2024 Apr; 16(2):339-352. PubMed ID: 38804373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain Injury Outcomes after Adjuvant Erythropoietin Neuroprotection for Moderate or Severe Neonatal Hypoxic-Ischemic Encephalopathy: A Report from the HEAL Trial.
    Wisnowski JL; Monsell SE; Bluml S; Goodman AM; Li Y; Comstock B; Heagerty P; Juul SE; Wu YW; McKinstry RC; Mathur A;
    Dev Neurosci; 2023 Oct; ():. PubMed ID: 37906983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.